Oral THC Improves Symptoms Of Schizophrenia, Study Says

Daily administration of oral synthetic THC significantly improves symptoms of schizophrenia, according to the findings of an open-label case series published this month in the Journal of Clinical Psychopharmacology.

Investigators at the Rockland Psychiatric Center in Orangeburg, New York, and the New York University School of Medicine, administered 2.5 to 5 mg doses of oral THC (dronabinol) for a period of eight weeks to six patients diagnosed with chronic, refractory schizophrenia. All of the patients enrolled in the study had reported previously using cannabis to mitigate their condition.